Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Retrospective Analysis of 56 Cases of Transformed Waldenström Macroglobulinemia. a Study on Behalf of the French Innovative Leukemia Organization (FILO)

Eric Durot, MD, Cecile Tomowiak, MD, Anne-Sophie Michallet, MD, Jehan Dupuis, MD, Stephane Lepretre, Elise Toussaint, MD, Sophie Godet, Fatiha Merabet, Eric W Van Den Neste, MD PhD, Sarah Ivanoff, Jean-Marc Zini, MD PhD, Caroline Régny, Aurore Perrot, MD, Lukshe Kanagaratnam, Pierre Morel, MD, Veronique Leblond, Alain Delmer, MD PhD

Blood (2016) 128 (22): 2982.

https://doi.org/10.1182/blood.V128.22.2982.2982

Published: 2016

Journal Articles

Clinical Resistance To Ruxolitinib Is More Frequent In Patients Without MPN-Associated Mutations and Is Rarely Due To Mutations In The JAK2 Kinase Drug-Binding Domain

Annalisa Andreoli, MD, Emmanuelle Verger, PhD, Marie Robin, MD, PhD, Emmanuel Raffoux, Jean-Marc Zini, MD, PhD, Philippe Rousselot, MD, PhD, Gérard Socié, MD, PhD, Delphine Rea, MD, PhD, Nathalie Parquet, MD, Stephane Giraudier, MD, PhD, Christine Chomienne, MD, PhD, Bruno Cassinat, PharmD, PhD, Jean-Jacques Kiladjian, MD, PhD

Blood (2013) 122 (21): 1591.

https://doi.org/10.1182/blood.V122.21.1591.1591

Published: 2013

Journal Articles

18 F-FLT Positron Emission Tomography (PET)/CT Imaging in Myelofibrosis: A Non Invasive Method to Assess Bone Marrow Function and Extramedullary Hematopoiesis

Annalisa Andreoli, MD, Laetitia Vercellino, Mathieu-John Ouvrier, Emmanuelle Barré, Bruno Cassinat, PharmD, PhD, Virginie de Beco, Jean-Marc Zini, MD, PhD, Pascal Merlet, MD, Christine Dosquet, MD, Christine Chomienne, MD, PhD, Marie-Elisabeth Toubert, Jean-Jacques Kiladjian, MD, PhD

Blood (2012) 120 (21): 1741.

https://doi.org/10.1182/blood.V120.21.1741.1741

Published: 2012

Journal Articles

Salvage Therapies in Patients with High-Risk Relapse After Fludarabine, Cyclophosphamide, Rituximab (FCR) for Chronic Lymphocytic Leukemia: The French CLL Intergroup Experience

Luc-Matthieu Fornecker, MD, Therese Aurran-Schleinitz, Anne-Sophie Michallet, MD, PhD, Bruno Cazin, MD, Jehan Dupuis, MD, Romain Guieze, MD, Marie-Sarah Dilhuydy, MD, Jean-Marc Zini, MD, PhD, Cécile Tomowiak, MD, Stéphane Leprêtre, MD, Florence Cymbalista, MD, PhD, Annie Brion, MD, Pierre Feugier, MD, PhD, Veronique Leblond, Loic Ysebaert, MD PhD

Blood (2012) 120 (21): 1796.

https://doi.org/10.1182/blood.V120.21.1796.1796

Published: 2012

Journal Articles

Complete Hematological, Molecular and Histological Remissions without Cytoreductive Treatment Lasting After Pegylated-Interferon α-2a (peg-IFNα-2a) Therapy in Polycythemia Vera (PV): Long Term Results of a Phase 2 Trial

Pascal Turlure, MD, Nathalie Cambier, MD, Murielle Roussel, Sylvia Bellucci, MD, PhD, Jean-Marc Zini, MD, PhD, Jean-Didier Rain, MD, Philippe Rousselot, MD, PhD, William Vainchenker, MD, PhD, Lina Abdelkader, Kamel Ghomari, Jean-Luc Dutel, Yasmine Chait, Sylvie Chevret, Christine Chomienne, MD, PhD, Bruno Cassinat, PharmD, Jean-Jacques Kiladjian, MD, PhD

Blood (2011) 118 (21): 280.

https://doi.org/10.1182/blood.V118.21.280.280

Published: 2011

NARROW

Retrospective Analysis of 56 Cases of Transformed Waldenström Macroglobulinemia. a Study on Behalf of the French Innovative Leukemia Organization (FILO)

Clinical Resistance To Ruxolitinib Is More Frequent In Patients Without MPN-Associated Mutations and Is Rarely Due To Mutations In The JAK2 Kinase Drug-Binding Domain

18 F-FLT Positron Emission Tomography (PET)/CT Imaging in Myelofibrosis: A Non Invasive Method to Assess Bone Marrow Function and Extramedullary Hematopoiesis

Salvage Therapies in Patients with High-Risk Relapse After Fludarabine, Cyclophosphamide, Rituximab (FCR) for Chronic Lymphocytic Leukemia: The French CLL Intergroup Experience

Complete Hematological, Molecular and Histological Remissions without Cytoreductive Treatment Lasting After Pegylated-Interferon α-2a (peg-IFNα-2a) Therapy in Polycythemia Vera (PV): Long Term Results of a Phase 2 Trial

Email alerts

ASH Publications

American Society of Hematology

Retrospective Analysis of 56 Cases of Transformed Waldenström Macroglobulinemia. a Study on Behalf of the French Innovative Leukemia Organization (FILO)

Clinical Resistance To Ruxolitinib Is More Frequent In Patients Without MPN-Associated Mutations and Is Rarely Due To Mutations In The JAK2 Kinase Drug-Binding Domain

18 F-FLT Positron Emission Tomography (PET)/CT Imaging in Myelofibrosis: A Non Invasive Method to Assess Bone Marrow Function and Extramedullary Hematopoiesis

Salvage Therapies in Patients with High-Risk Relapse After Fludarabine, Cyclophosphamide, Rituximab (FCR) for Chronic Lymphocytic Leukemia: The French CLL Intergroup Experience

Complete Hematological, Molecular and Histological Remissions without Cytoreductive Treatment Lasting After Pegylated-Interferon α-2a (peg-IFNα-2a) Therapy in Polycythemia Vera (PV): Long Term Results of a Phase 2 Trial

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only